Search

Your search keyword '"Tsimafeyeu, Ilya"' showing total 251 results

Search Constraints

Start Over You searched for: Author "Tsimafeyeu, Ilya" Remove constraint Author: "Tsimafeyeu, Ilya"
251 results on '"Tsimafeyeu, Ilya"'

Search Results

6. Maintenance therapy with avelumab as the first-line treatment in patients with metastatic urothelial carcinoma: A real-world, ambispective RAVE-Bladder study.

7. Sunitinib in Patients with Metastatic Renal Cell Carcinoma with Favorable Risk: Be Aware of PD-L1 Expression.

9. Immunotherapy in cancer patients with chronic hepatitis C viral infection

14. Radiotherapy for Hepatocellular Carcinoma in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise

25. Bridging the Gap in Global Advanced Radiation Oncology Training: Impact of a Web-Based Open-Access Interactive Three-Dimensional Contouring Atlas on Radiation Oncologist Practice in Russia

26. Multicenter phase 2 study of intrapleural nivolumab in patients with metastatic non-small cell lung cancer and pleural effusion

27. Intrapleural nivolumab in cancer patients with pleural effusion.

29. A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancer

31. Challenges to effective cancer control in China, India, and Russia

32. Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer

33. Abstract 3481: Pharmacokinetics of alofanib and biomarker analysis in patients with advanced gastric cancer: A phase 1b study

36. Alofanib in subsequent therapy for advanced gastric cancer: Final results from the phase Ib clinical trial.

39. A first-in-human phase 1b study of a novel allosteric extracellular FGFR2 inhibitor alofanib in patients with refractory metastatic gastric cancer.

42. The association of access to systemic therapy and overall survival in metastatic bladder cancer in Russia: An analysis of URRU register.

43. Abstract CT113: Preliminary data on a phase 1b, first-in-human study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with refractory metastatic gastric cancer

45. COVID-19 in Patients With Renal Cell Carcinoma in the Russian Federation

49. Overall survival in patients with metastatic renal cell carcinoma in Russia, Kazakhstan, and Belarus: a report from the RENSUR3 registry

Catalog

Books, media, physical & digital resources